A. B. FERHANOĞLU Et Al. , "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience.," EHA24, 24th International Congress of European Hematology Association , Amsterdam, Netherlands, 2019
FERHANOĞLU, A. B. Et Al. 2019. Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience.. EHA24, 24th International Congress of European Hematology Association , (Amsterdam, Netherlands).
FERHANOĞLU, A. B., ÖZBALAK, M. M., BEKÖZ, H. S., KARADURMUŞ, N., PAYDAŞ, S., TÜRKER, F. A., ... TOPTAŞ, T.(2019). Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience. . EHA24, 24th International Congress of European Hematology Association, Amsterdam, Netherlands
FERHANOĞLU, AHMET Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience.," EHA24, 24th International Congress of European Hematology Association, Amsterdam, Netherlands, 2019
FERHANOĞLU, AHMET B. Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience.." EHA24, 24th International Congress of European Hematology Association , Amsterdam, Netherlands, 2019
FERHANOĞLU, A. B. Et Al. (2019) . "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience.." EHA24, 24th International Congress of European Hematology Association , Amsterdam, Netherlands.
@conferencepaper{conferencepaper, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience.}, congress name={EHA24, 24th International Congress of European Hematology Association}, city={Amsterdam}, country={Netherlands}, year={2019}}